Globus Medical, Inc. GMED · SEC Filings

6K

Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and ...

Price76.37

Market Cap10.25 B

Float133.3 M

CountryUS

SectorHealthcare

ExchangeNYSE

Overview Filings Insights Dilution News Transcripts

Search in Documents

Open in Studio Login

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 5, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 6, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 7, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 24, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 6, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 7, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Globus Medical Reports Third Quarter 2026 Results and Announces a $500 Million Increase to the Share Repurchase Program

Nov 5, 2026

8-K

Globus Medical Reports Second Quarter 2026 Financial Results

Aug 6, 2026

8-K

Globus Medical, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jun 4, 2026

8-K

Globus Medical Reports Strong First Quarter 2026 Financial Results

May 7, 2026

8-K

Globus Medical Announces Departure of Director John A. DeFord

Mar 23, 2026

8-K

Globus Medical Reports Strong Fourth Quarter and Full Year 2025 Financial Results

Feb 24, 2026

Prospectus

TYPE

HEADLINE

FILED AT

425

Form 425 - Prospectuses and communications, business combinations

Apr 27, 2023

425

Form 425 - Prospectuses and communications, business combinations

Apr 17, 2023

425

Form 425 - Prospectuses and communications, business combinations

Apr 3, 2023

424B3

Form 424B3 - Prospectus [Rule 424(b)(3)]

Mar 28, 2023

425

Form 425 - Prospectuses and communications, business combinations

Feb 22, 2023

425

Form 425 - Prospectuses and communications, business combinations

Feb 9, 2023

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Nov 30, 2023

S-4/A

Form S-4/A - Registration of securities, business combinations: [Amend]

Mar 24, 2023

S-4

Form S-4 - Registration of securities, business combinations

Mar 10, 2023

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Dec 16, 2021

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Sep 12, 2014

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Sep 28, 2012

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 24, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 24, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 25, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 25, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 26, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 26, 2024

Ownerships

TYPE

HEADLINE

FILED AT

4

RHOADS ANN D (Reporting)

Nov 5, 2026

144

Form 144 - Report of proposed sale of securities

Nov 4, 2026

SCHEDULE 13G/A

VANGUARD CAPITAL MANAGEMENT LLC (Filed by)

Oct 30, 2026

SCHEDULE 13G/A

BlackRock, Inc. (Filed by)

Oct 27, 2026

4

TOBIN JAMES R (Reporting)

Sep 16, 2026

144

Form 144 - Report of proposed sale of securities

Sep 15, 2026

Other

TYPE

HEADLINE

FILED AT

SD

Form SD - Specialized disclosure report

May 27, 2026

SD

Form SD - Specialized disclosure report

May 29, 2025

LETTER

Form UPLOAD - SEC-generated letter

Oct 4, 2024

CORRESP

Form CORRESP - Correspondence

Oct 2, 2024

LETTER

Form UPLOAD - SEC-generated letter

Sep 19, 2024

SD

Form SD - Specialized disclosure report

May 31, 2024